FEMS MicrobesMicrobiologyPeer-reviewed journal article
Plasticity in a bacterial global regulatory switch that drives a shift in antibiotic resistance and virulence
Annapaula CorreiaiD, Emma Jayne MannersiD, Benjamin Andrew EvansiD, Jacob G. MaloneiD, Justin O’GradyiD, Eleni MavrogiorgouiD, Sergio Arminu, Manuela Usai, Dixita NaikiD, Stuart McMillaniD, Gemma L. KayiD, Claire HilliD, Padhmanand SudhakariD, Emma J. Meader, Katarzyna Schmidt, Tamas Douglas KorcsmarosiD, Andrew P. DesboisiD, Lisa C. CrossmaniD, John R. WainiD, Gemma C. LangridgeiD
Abstract
Antibiotic resistance and expression of virulence factors can impact the outcome of infection by Pseudomonas aeruginosa. Pathogenesis is often modelled using the P. aeruginosa PAO1 reference strain but laboratory lineages vary in the sequence and activity of MexT, a global regulator impacting virulence, biofilm formation and ciprofloxacin resistance. We defined the impact of active versus inactive MexT in PAO1 and observed global transcriptomic changes affecting the expression of 900 genes. Phenotyping revealed altered metabolism, antibiotic resistance and virulence - resulting in striking variation across a single model organism. We propose that antibiotic-resistance, introduced during work with the original PAO1 strain, has caused plasticity in mexT that accounts for variation across lineages. To test this, we introduced antibiotic resistance into clinical P. aeruginosa isolates and observed downstream mutations in mexT when selective pressure was removed, supporting the proposed evolutionary pathway. Overall, we have demonstrated the transcriptomic basis of MexT as a phenotypic switch in PAO1 and implicated antibiotic resistance as a cause of downstream changes in mexT in P. aeruginosa. Furthermore, MexS/MexT-regulated efflux is implicated in the antibiotic stress response and virulence, helping identify the mechanisms for rapid phenotypic switching through mexT and confirming that PAO1 is a very different organism compared to most isolates. Improved understanding of the regulatory changes linked to antibiotic resistance is particularly relevant to P. aeruginosa where cycles of antibiotic treatment are common.
- organism: bacteria (other)
- assay: whole-genome sequencing
- assay: proteomics
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: genetic perturbation / CRISPR
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heterogeneity during induction of resistance delays Pseudomonas aeruginosa recovery from antibiotic exposures.
David Ritz, Rachel Martin, … Daniel Schultz·bioRxiv·Sep 20, 2024
- Efflux pump mutations in Pseudomonas aeruginosa cause low-level clinical resistance and high-level tolerance to antibiotics in patients
P. Laborda, S. Lolle, … H. K. Johansen·bioRxiv·Aug 18, 2023
- In vitro exposure to non-antipseudomonal antibiotics (NAPA) induces Pseudomonas aeruginosa resistance to antipseudomonal antibiotics (APA)
David Lasry, Luke B. Harrison, … Alexander Lawandi·Journal of Antimicrobial ChemotherapyPeer-reviewed·May 5, 2026
- Evaluating the Link Between Efflux Pump Expression and Motility Phenotypes in Pseudomonas aeruginosa Treated with Virulence Inhibitors
Hannah K. Lembke, Kelsie M. Nauta, … Erin E. Carlson·ACS Infectious DiseasesPeer-reviewed·Apr 27, 2025
- Global reprogramming of virulence and antibiotic resistance in Pseudomonas aeruginosa by a single nucleotide polymorphism in the elongation factor-encoding gene, fusA1.
E. A. Maunders, R. Triniman, … M. Welch·bioRxiv·Nov 15, 2019
- Variation in the response to antibiotics and life-history across the major Pseudomonas aeruginosa clone type (mPact) panel
L. Tueffers, A. Batra, … H. Schulenburg·bioRxiv·Jan 15, 2024